Immunometabolic Reprogramming and β-cell Dedifferentiation: Integrated Mechanisms Driving Type 2 Diabetes Progression

The authors synthesize current evidence to illustrate how metabolic and immune pathways converge on key molecular regulators of β-cell fate.